What Is IGF-1 LR3?
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a modified analog of naturally occurring IGF-1 designed for extended activity in controlled laboratory environments.
Compared to native IGF-1, IGF-1 LR3 includes:
- Arginine substitution at position 3
- 13 additional amino acids at the N-terminus
- Reduced binding affinity to IGF binding proteins (IGFBPs)
- Extended half-life in research models
These structural modifications make IGF-1 LR3 1mg a commonly studied compound in cellular signaling and growth factor research.
IGF-1 LR3 Mechanism of Action (Research Context)
IGF-1 LR3 binds to the IGF-1 receptor (IGF-1R), activating intracellular signaling pathways such as:
- PI3K / Akt pathway
- MAPK / ERK pathway
These pathways are associated in scientific literature with:
- Cellular proliferation
- Protein synthesis signaling
- Nutrient utilization research
- Growth factor regulation
Because IGF-1 LR3 has reduced affinity for binding proteins, it may allow for prolonged receptor interaction in experimental settings.
Why Researchers Study IGF-1 LR3 1mg
1. Cellular Growth Models
Investigated in laboratory environments evaluating cell proliferation and differentiation.
2. Protein Synthesis Signaling
Studied in relation to anabolic pathway markers.
3. Metabolic Pathway Research
Explored in glucose utilization and insulin-related cellular signaling models.
4. Tissue Development Research
Used in controlled studies examining regenerative signaling pathways.
Structural Advantages of IGF-1 LR3
Compared to native IGF-1:
- Extended half-life (often cited up to 20–30 hours in models)
- Lower IGFBP binding
- Longer receptor activation window
This extended activity profile is why IGF-1 LR3 1mg remains a staple in peptide research environments.
Research Handling & Laboratory Use
IGF-1 LR3 is intended for research use only and is handled in controlled laboratory settings. Proper storage, reconstitution, and microgram-level precision are critical in experimental design.
RELATED RESEARCH PEPTIDES: